查看更多>>摘要:By a News Reporter-Staff News Editor at Robotics & Machine Learning Daily News Daily News-New research on Oncology-Bladder Can cer is the subject of a report. According to news reporting originating from Tia njin, People's Republic of China, by NewsRx correspondents, research stated, "To evaluate the safety and effectiveness of robot-assisted radical cystectomy (RAR C), laparoscopic radical cystectomy (LRC), and open radical cystectomy (ORC) in bladder cancer. A literature search for network meta-analysis was conducted usin g international databases up to February 29, 2024." Our news editors obtained a quote from the research from Tianjin First Central H ospital, "Outcomes of interest included baseline characteristics, perioperative outcomes and oncological outcomes. Forty articles were finally selected for incl usion in the network meta-analysis. Both LRC and RARC were associated with longe r operative time, smaller amount of estimated blood loss, lower transfusion rate , shorter time to regular diet, fewer incidences of complications, and fewer pos itive surgical margin compared to ORC. LRC had a shorter time to flatus than ORC , while no difference between RARC and ORC was observed. Considering lymph node yield, there were no differences among LRC, RARC and ORC. In addition, there wer e statistically significant lower transfusion rates (OR=-0.15, 95% CI=-0.47 to 0.17), fewer overall complication rates (OR=-0.39, 95% CI=-0.79 to 0.00), fewer minor complication rates (OR=-0.23, 95% C I=-0.48 to 0.02), fewer major complication rates (OR=-0.23, 95% CI =-0.68 to 0.21), fewer positive surgical margin rates (OR=0.22, 95% CI=-0.27 to 0.68) in RARC group compared with LRC group. LRC and RARC could be c onsidered as a feasible and safe alternative to ORC for bladder cancer. Notably, compared with LRC, RARC may benefit from significantly lower transfusion rates, fewer complications and lower positive surgical margin rates."